Effect of Xylocaine 4% Solution on Patient's Anxiety with Nasal Packing After Septoplasty
DOI:
https://doi.org/10.52206/jsmc.2022.12.1.525Abstract
Background: Removal of nasal pack after septoplasty causes pain and anxiety in patients. Xylocaine 4% solution used as topical anesthetic reduces pain and anxiety if infiltrated postoperatively into nasal packing.
Objective: To evaluate the effect of xylocaine 4% solution on patient's anxiety infiltrated in to nasal pack after septoplasty.
Material and Methods: This prospective case control study conducted at the ENT and Psychiatry departments of Gajju Khan Medical College (GKMC) Swabi from June 2019 to December 2019. A total of 100 patients who underwent septoplasty with bilateral antibiotic ointment soaked nasal packing were randomly divided in to two groups, A & B. Xylocaine 4% solution (5ml in each nostril) was infiltrated into nasal pack in 50 patients in group A while group B including 50 patients were infiltrated with liquid paraffin (5ml in each nostril) fifteen minutes before nasal pack removal.
Results: A total of 100 patients were included with age ranging from 18 to 40 years with a mean age of 25.2 years with male predominance. Hamilton anxiety scale scores in Xylocaine group were11.81+3.47, 15.05+2.99 and 10.6+3.51 at 24 hrs before surgery, 24hrs after surgery and 20 minutes after pack removal while 10.4+4.34, 14.21+4.13 and 12.6+4.54 were in the liquid paraffin group which suggests that anxiety was less in the xylocaine group at 20 minutes after pack removal.
Conclusion: There was significant reduction in pain and anxiety after infiltration of xylocaine 4% solution into nasal pack post septoplasty.
KEY WORDS: Xylocaine, Anxiety, Septoplasty
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 The authors retain the copyrights. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their website), as it can lead to productive exchanges, as well as greater citation of published work.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
